ReachMD

Be part of the knowledge.™

Women's Health

602

LikeLikedUnlike

Episodes 16-30 of 52

- Lee P. Shulman, MD, FACMG, FACOG
  Peer
- Kenneth J. Moise Jr., MD
  Peer
9
CME/CE
Hemolytic Disease of the Fetus and Newborn: Cutting Edge Strategies for Diagnosis and Management
Hemolytic Disease of the Fetus and Newborn: Cutting Edge Strategies for Diagnosis and Management
0.25 credits
- Pradeep Y. Ramulu, MD, PhD
  Peer
- E. Randy Craven, MD
  Peer
- Mark T. Dunbar, OD, FAAO
  Peer
7
CME/CE
Innovations in Glaucoma Therapy
Innovations in Glaucoma Therapy
0.25 credits
- Kevin Garey, PharmD, MS
  Peer
- A. Krishna Rao, MD, MS
  Peer
9
CME/CE
The Changing Landscape of Clostridioides difficile Infections
The Changing Landscape of Clostridioides difficile Infections
0.25 credits
- David L. Eisenberg, MD, MPH, FACOG
  Peer
- David J. Portman, MD
  Peer
15
CME/CE
A New Era Begins in Contraception: The Vaginal Gel pH Modulator
A New Era Begins in Contraception: The Vaginal Gel pH Modulator
0.25 credits
- William Mencia, MD, FACEHP, CHCP
  Peer
- Sateria Venable
  Peer
12
CME/CE
Health Disparities in the Management of Uterine Fibroids
Health Disparities in the Management of Uterine Fibroids
0.25 credits
- Anita L. Nelson, MD
  Peer
- David J. Portman, MD
  Peer
9
CME/CE
Expanding Choices in Combined Hormonal Contraceptives—Seeing Beyond LARCs
Expanding Choices in Combined Hormonal Contraceptives—Seeing Beyond LARCs
0.25 credits
- Lee P. Shulman, MD, FACMG, FACOG
  Peer
- Anita L. Nelson, MD
  Peer
12
CME/CE
Expanding Contraceptive Choices Beyond Long-Acting Reversible Methods
Expanding Contraceptive Choices Beyond Long-Acting Reversible Methods
0.25 credits
- Pradeep Y. Ramulu, MD, PhD
  Peer
- Ian Benjamin Gaddie, OD, FAAO
  Peer
9
CME/CE
Glaucoma: Therapeutic Advances on the Cutting Edge
Glaucoma: Therapeutic Advances on the Cutting Edge
0.25 credits
- Richard T. Penson, MD, MRCP
  Peer
- Linda R. Duska, MD, MPH
  Peer
16
CME/CE
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
0.25 credits
- Mark Dunbar, OD, FAAO
  Peer
- Diana V. Do, MD
  Peer
4
CME/CE
A National Eye Institute Initiative—Ensuring the Health of Patients and Staff in Eye Health Practices During COVID-19
A National Eye Institute Initiative—Ensuring the Health of Patients and Staff in Eye Health Practices During COVID-19
0.25 credits
- Diana Shechtman, OD, FAAO
  Peer
- Charles Wykoff, MD, PhD
  Peer
3
CME/CE
A National Eye Institute Initiative—Practice Strategies to Optimize Continuity of Care for Eye Health During COVID-19
A National Eye Institute Initiative—Practice Strategies to Optimize Continuity of Care for Eye Health During COVID-19
0.25 credits
- Sara Hurvitz, MD
  Peer
- Jacob Sands, MD
  Peer
8
CME/CE
Clinical Considerations for Targeted Therapies Across Multiple Tumor Types
Clinical Considerations for Targeted Therapies Across Multiple Tumor Types
0.25 credits
- Christopher P. Cannon, MD
  Peer
- Samuel Dagogo-Jack, MD, DSc
  Peer
10
CME/CE
Is It Time to Change Your Treatment Strategy for Type 2 Diabetes Patients with CV Risks?
Is It Time to Change Your Treatment Strategy for Type 2 Diabetes Patients with CV Risks?
0.25 credits
- William J. Gradishar MD, FASCO, FACP
  Peer
- Peter Schmid, FRCP, MD, PhD
  Peer
6
CME/CE
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Metastatic Breast Cancer
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Metastatic Breast Cancer
0.25 credits
- Kevin C.J. Yuen, MD
  Peer
- Patricia M. Buckley
  Peer
3
CME/CE
The Patient Voice in Adult Growth Hormone Deficiency
The Patient Voice in Adult Growth Hormone Deficiency

Loading...

Programs 2/28/21

Segment Chapters

Playlist:

Recommended